Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Calquence Phase III ASCEND trial met primary endpoint at interim analysis in relapsed or refractory chronic lymphocytic leukaemia and will stop early
-
Qternmet XR approved in the US for the treatment of type-2 diabetes
-
AstraZeneca starts artificial intelligence collaboration to accelerate drug discovery
-
Lynparza receives positive EU CHMP opinion for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer
-
Q1 2019 Results
-
Lynparza approved in EU for the treatment of germline BRCA-mutated HER2-negative advanced breast cancer
-
Positive results from Fasenra Phase II trial in hypereosinophilic syndrome published in New England Journal of Medicine
-
Selumetinib granted US Breakthrough Therapy Designation in neurofibromatosis type 1
-
Proposed placing of new ordinary shares
-
AstraZeneca and Daiichi Sankyo enter collaboration for novel HER2-targeting antibody-drug conjugate
Latest articles and press releases
All of our latest press releases and articles are available to explore
